Signaling pathways
-
BA7043 BAY-390Summary: BAY-390 is a selective, cross-species active, brain penetrating inhibitor. - BA7044 EvifacotrepSummary: Evfacotrep is a short-term transient receptor potential channel 5 antagonist for neurological disorders.
- BA7045 PF-05105679Summary: PF-05105679 is an orally active, selective antagonist.
- BA7046 TRPC6-IN-1Summary: TRPC6-IN-1 is an inhibitor.
- BA7047 GDC-6599Summary: GDC-6599 is an orally effective inhibitor.
- BA7048 GFB-8438Summary: GFB-8438 is a potent subtype-selective inhibitor with 0.18 and 0.29 μM for hTRPC5 and hTRPC4, respectively.
- BA7049 MDR-652Summary: MDR-652 is a highly potent specific transient receptor potential vanilloid subtype 1 ligand with agonist activity.
- BA7050 TRPA1-IN-2Summary: TRPA1-IN-2 is a potent orally active inhibitor.
- BA7051 VoacangineSummary: Voacangine is an antagonist of and but also an agonist.
- BA7052 TRPC6-IN-3Summary: TRPC6-IN-3 is an orally potent transient receptor potential C6 ion channel inhibitor.